JPMORGAN CHASE & CO - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$266,579
-23.3%
76,824
+2.8%
0.00%
Q2 2023$347,397
+4.6%
74,709
+4.2%
0.00%
Q1 2023$332,000
+21785.3%
71,669
-61.8%
0.00%
Q4 2022$1,517
-99.8%
187,778
+20.7%
0.00%
Q3 2022$864,000
+6.0%
155,577
-0.5%
0.00%
Q2 2022$815,000
-41.9%
156,431
-8.4%
0.00%
Q1 2022$1,403,000
+67.8%
170,766
+204.1%
0.00%
Q4 2021$836,000
-21.9%
56,156
-1.0%
0.00%
Q3 2021$1,071,000
-8.8%
56,719
-10.2%
0.00%
Q2 2021$1,174,000
-12.7%
63,148
+6.9%
0.00%
Q1 2021$1,345,000
-7.0%
59,087
-11.3%
0.00%
Q4 2020$1,447,000
+94.2%
66,597
-8.0%
0.00%
Q3 2020$745,000
+16.4%
72,412
-12.2%
0.00%
Q2 2020$640,000
-38.3%
82,472
-19.0%
0.00%
Q1 2020$1,038,000
-8.8%
101,873
-1.5%
0.00%
Q4 2019$1,138,000
+27.0%
103,418
+4.9%
0.00%
Q3 2019$896,000
-16.9%
98,542
+3.7%
0.00%
Q2 2019$1,078,000
-1.3%
95,039
-0.9%
0.00%
Q1 2019$1,092,000
+21.6%
95,860
-3.6%
0.00%
Q4 2018$898,000
-40.2%
99,451
-0.6%
0.00%
Q3 2018$1,501,000100,0500.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,675,579$5,814,2591.78%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,883,693$20,416,4151.10%
Kynam Capital Management, LP 1,552,675$5,387,7820.88%
Parkman Healthcare Partners LLC 1,182,168$4,102,1230.75%
Rubric Capital Management LP 3,344,810$11,606,4910.44%
BVF INC/IL 3,347,946$11,617,3730.31%
DAFNA Capital Management LLC 283,079$982,2840.31%
SECTORAL ASSET MANAGEMENT INC 432,339$1,500,2160.29%
Eversept Partners, LP 769,638$2,670,6440.23%
Frazier Life Sciences Management, L.P. 780,000$2,706,6000.18%
View complete list of SUTRO BIOPHARMA INC shareholders